<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One hundred five unselected and consecutive patients were prospectively studies after <z:hpo ids='HP_0011009'>acute</z:hpo> transmural <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> to assess the incidence of <z:e sem="disease" ids="C0333205,C1260883" disease_type="Disease or Syndrome" abbrv="">mural thrombus</z:e> formation and to relate the presence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> to patient outcome in terms of systemic embolic events, functional class and survival </plain></SENT>
<SENT sid="1" pm="."><plain>In 87 patients, optimal quality two-dimensional echocardiographic studies were obtained and were repeated at daily intervals to detect <z:e sem="disease" ids="C0333205,C1260883" disease_type="Disease or Syndrome" abbrv="">mural thrombus</z:e> formation </plain></SENT>
<SENT sid="2" pm="."><plain>The site of infarction was anterior in 53 patients and inferior in 34 </plain></SENT>
<SENT sid="3" pm="."><plain>On admission, <z:hpo ids='HP_0000001'>all</z:hpo> patients received subcutaneous <z:chebi fb="5" ids="28304">heparin</z:chebi> and antiplatelet agents (aspirin, <z:chebi fb="0" ids="4653">dipyridamole</z:chebi>); none received full <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Left ventricular <z:e sem="disease" ids="C0333205,C1260883" disease_type="Disease or Syndrome" abbrv="">mural thrombus</z:e> was visualized between 2 and 11 days (median 6) after the clinical <z:hpo ids='HP_0003674'>onset</z:hpo> of infarction in 21 (40%) of the 53 patients with anterior infarction </plain></SENT>
<SENT sid="5" pm="."><plain>No patients with inferior infarction had echocardiographic evidence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="6" pm="."><plain>During follow-up of 22 to 51 months (mean 39), none of the 21 patients with <z:e sem="disease" ids="C0333205,C1260883" disease_type="Disease or Syndrome" abbrv="">mural thrombus</z:e> had clinical evidence of <z:mpath ids='MPATH_118'>systemic embolism</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>One patient with inferior and one with anterior infarction had a cerebral <z:mpath ids='MPATH_110'>embolus</z:mpath> 7 days and 9 months, respectively, after the <z:hpo ids='HP_0011009'>acute</z:hpo> event, but neither of these patients had echocardiographic evidence of <z:e sem="disease" ids="C0587044" disease_type="Disease or Syndrome" abbrv="">left ventricular thrombus</z:e> at any stage </plain></SENT>
<SENT sid="8" pm="."><plain>Echocardiography performed at 1 and 2 years of follow-up showed persistent evidence of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> in only 8 (31%) and 5 (24%) of the 21 patients, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>On admission, the functional class of patients with anterior <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> was similar to that of patients without ventricular <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e>.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>